论文部分内容阅读
乙型肝炎病毒(HBV)感染引起的慢性活动性肝炎(以下简称慢活肝)是一种难治的传染病。近十余年来由于免疫学理论和实验技术的进展,对本病发病机理的研究起到了明显的推动作用。到目前为止已有许多文献资料证明,由HBV感染引起的自身免疫反应,在本病的发生和发展过程中起重要作用。基于这种观点,近十年来广泛地应用了免疫药物对慢活肝进行治疗。至今,不仅多年来一直使用的免疫抑制药物(如肾上腺皮质激素、硫唑嘌
Chronic active hepatitis caused by Hepatitis B virus (HBV) infection is an intractable infectious disease. In the recent ten years, due to the progress of immunology theory and experimental technology, the research on the pathogenesis of this disease has played a significant role in promoting. So far, there is a lot of literature to prove that the autoimmune reaction caused by HBV infection plays an important role in the occurrence and development of this disease. Based on this view, immune drugs have been widely used in the last decade to treat slow-lived livers. To date, not only immunosuppressive drugs that have been used for many years (such as adrenocorticoids, azathioprine